MoneyWorks4Me

Ajanta Pharma informs about disclosure

17 Jun 2025 Evaluate
Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 16, 2025 for Aayush Agrawal, trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1859.90
Dr. Reddys Labs. 1173.00
Cipla 1379.10
Lupin 2080.00
Zydus Lifesciences 1136.70
View more..